Mettler-Toledo International Inc. (MTD) Spending and interest coverage
- R&D / revenue · 12 months: Value 5.03%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.55%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 5.03% | Research and development expense / revenue. Period ending 2026-06-30. $208.01M ÷ $4.13B × 100 ≈ 5.03% |
| Stock-based compensation / revenue · 12 months | 0.55% | Share-based compensation / revenue. Period ending 2026-06-30. $22.83M ÷ $4.13B × 100 ≈ 0.55% |
| Interest coverage · 12 months | (m) | Operating income ÷ reported interest expense. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 208.01M USD | Research and Development Expense |
| Revenue | 4.13B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 22.83M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | (m) | |
| Interest expense · reported / estimated | 69.34M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $208.01M | $4.13B | $22.83M | (m) | $69.34M | 5.03% | 0.55% | (m) | Reported |
| 2026-03-31 | $204.30M | $4.09B | $22.84M | (m) | $68.87M | 5.00% | 0.56% | (m) | Reported |
| 2025-12-31 | $199.37M | $4.03B | $22.51M | (m) | $68.52M | 4.95% | 0.56% | (m) | Reported |
| 2025-09-30 | $196.83M | $3.94B | $22.38M | (m) | $68.98M | 4.99% | 0.57% | (m) | Reported |
| 2025-06-30 | $192.80M | $3.87B | $21.24M | (m) | $69.88M | 4.99% | 0.55% | (m) | Reported |
| 2025-03-31 | $189.29M | $3.83B | $20.40M | (m) | $72.05M | 4.94% | 0.53% | (m) | Reported |
| 2024-12-31 | $189.36M | $3.87B | $19.98M | (m) | $74.63M | 4.89% | 0.52% | (m) | Reported |
| 2024-09-30 | $185.74M | $3.76B | $19.10M | (m) | $76.44M | 4.94% | 0.51% | (m) | Reported |
| 2024-06-30 | $184.75M | $3.75B | $18.97M | (m) | $78.11M | 4.93% | 0.51% | (m) | Reported |
| 2024-03-31 | $186.22M | $3.79B | $18.62M | (m) | $78.41M | 4.92% | 0.49% | (m) | Reported |
| 2023-12-31 | $185.28M | $3.79B | $17.93M | (m) | $77.37M | 4.89% | 0.47% | (m) | Reported |
| 2023-09-30 | $184.79M | $3.91B | $18.18M | (m) | $74.52M | 4.72% | 0.46% | (m) | Reported |
| 2023-06-30 | $182.79M | $3.95B | $18.68M | (m) | $68.72M | 4.62% | 0.47% | (m) | Reported |
| 2023-03-31 | $179.57M | $3.95B | $19.18M | (m) | $62.24M | 4.55% | 0.49% | (m) | Reported |
| 2022-12-31 | $177.12M | $3.92B | $19.66M | (m) | $55.39M | 4.52% | 0.50% | (m) | Reported |
| 2022-09-30 | $176.79M | $3.90B | $19.63M | (m) | $50.13M | 4.53% | 0.50% | (m) | Reported |
| 2022-06-30 | $174.94M | $3.87B | $19.64M | (m) | $47.44M | 4.53% | 0.51% | (m) | Reported |
| 2022-03-31 | $173.52M | $3.81B | $19.53M | (m) | $45.11M | 4.55% | 0.51% | (m) | Reported |
| 2021-12-31 | $169.77M | $3.72B | $19.59M | (m) | $43.24M | 4.57% | 0.53% | (m) | Reported |
| 2021-09-30 | $164.02M | $3.62B | $19.33M | (m) | $41.21M | 4.53% | 0.53% | (m) | Reported |
| 2021-06-30 | $156.40M | $3.47B | $19.02M | (m) | $38.73M | 4.50% | 0.55% | (m) | Reported |
| 2021-03-31 | $144.99M | $3.24B | $18.87M | (m) | $37.87M | 4.47% | 0.58% | (m) | Reported |
| 2020-12-31 | $140.10M | $3.09B | $18.69M | (m) | $38.62M | 4.54% | 0.61% | (m) | Reported |
| 2020-09-30 | $135.54M | $2.99B | $18.25M | (m) | $38.75M | 4.53% | 0.61% | (m) | Reported |
| 2020-06-30 | $136.90M | $2.94B | $18.28M | (m) | $39.24M | 4.66% | 0.62% | (m) | Reported |
| 2020-03-31 | $142.28M | $2.98B | $18.20M | (m) | $38.54M | 4.78% | 0.61% | (m) | Reported |
| 2019-12-31 | $143.95M | $3.01B | $18.29M | (m) | $37.41M | 4.78% | 0.61% | (m) | Reported |
| 2019-09-30 | $144.85M | $2.98B | $18.36M | (m) | $36.62M | 4.86% | 0.62% | (m) | Reported |
| 2019-06-30 | $143.68M | $2.96B | $18.16M | (m) | $35.82M | 4.85% | 0.61% | (m) | Reported |
| 2019-03-31 | $142.41M | $2.95B | $17.71M | (m) | $35.25M | 4.82% | 0.60% | (m) | Reported |
| 2018-12-31 | $141.07M | $2.94B | $17.58M | (m) | $34.51M | 4.81% | 0.60% | (m) | Reported |
| 2018-09-30 | $138.15M | $2.90B | $17.26M | (m) | $34.30M | 4.77% | 0.60% | (m) | Reported |
| 2018-06-30 | $135.51M | $2.86B | $17.02M | (m) | $33.54M | 4.74% | 0.60% | (m) | Reported |
| 2018-03-31 | $132.78M | $2.79B | $17.11M | (m) | $33.40M | 4.76% | 0.61% | (m) | Reported |
| 2017-12-31 | $129.26M | $2.73B | $16.58M | (m) | $32.78M | 4.74% | 0.61% | (m) | Reported |
| 2017-09-30 | $126.88M | $2.66B | $16.27M | (m) | $31.57M | 4.78% | 0.61% | (m) | Reported |
| 2017-06-30 | $124.54M | $2.61B | $15.85M | (m) | $30.49M | 4.77% | 0.61% | (m) | Reported |
| 2017-03-31 | $122.39M | $2.56B | $15.47M | (m) | $29.19M | 4.77% | 0.60% | (m) | Reported |
| 2016-12-31 | $119.97M | $2.51B | $15.31M | (m) | $28.03M | 4.78% | 0.61% | (m) | Reported |
| 2016-09-30 | $120.92M | $2.47B | $14.74M | (m) | $27.37M | 4.89% | 0.60% | (m) | Reported |
| 2016-06-30 | $120.50M | $2.43B | $14.49M | (m) | $27.24M | 4.97% | 0.60% | (m) | Reported |
| 2016-03-31 | $119.59M | $2.40B | $14.38M | (m) | $27.31M | 4.98% | 0.60% | (m) | Reported |
| 2015-12-31 | $119.08M | $2.40B | $14.22M | (m) | $27.45M | 4.97% | 0.59% | (m) | Reported |
| 2015-09-30 | $119.29M | $2.42B | $14.18M | (m) | $27.62M | 4.93% | 0.59% | (m) | Reported |
| 2015-06-30 | $119.93M | $2.44B | $14.09M | (m) | $26.58M | 4.91% | 0.58% | (m) | Reported |
| 2015-03-31 | $122.26M | $2.47B | $13.91M | (m) | $25.60M | 4.95% | 0.56% | (m) | Reported |
| 2014-12-31 | $123.30M | $2.49B | $13.61M | (m) | $24.54M | 4.96% | 0.55% | (m) | Reported |
| 2014-09-30 | $122.57M | $2.47B | $13.44M | (m) | $23.82M | 4.96% | 0.54% | (m) | Reported |
| 2014-06-30 | $121.27M | $2.44B | $13.29M | (m) | $23.39M | 4.98% | 0.55% | (m) | Reported |
| 2014-03-31 | $118.14M | $2.41B | $13.04M | (m) | $22.98M | 4.91% | 0.54% | (m) | Reported |
| 2013-12-31 | $116.35M | $2.38B | $12.64M | (m) | $22.71M | 4.89% | 0.53% | (m) | Reported |
| 2013-09-30 | $113.75M | $2.35B | $12.95M | (m) | $22.17M | 4.84% | 0.55% | (m) | Reported |
| 2013-06-30 | $112.60M | $2.34B | $13.08M | (m) | $22.18M | 4.81% | 0.56% | (m) | Reported |
| 2013-03-31 | $111.56M | $2.33B | $12.69M | (m) | $22.34M | 4.79% | 0.54% | (m) | Reported |
| 2012-12-31 | $112.53M | $2.34B | $13.19M | (m) | $22.76M | 4.81% | 0.56% | (m) | Reported |
| 2012-09-30 | $114.64M | $2.33B | $12.66M | (m) | $23.03M | 4.91% | 0.54% | (m) | Reported |
| 2012-06-30 | $116.82M | $2.36B | $12.50M | (m) | $23.35M | 4.96% | 0.53% | (m) | Reported |
| 2012-03-31 | $118.45M | $2.35B | $12.39M | (m) | $23.34M | 5.05% | 0.53% | (m) | Reported |
| 2011-12-31 | $116.14M | $2.31B | $12.27M | (m) | $23.23M | 5.03% | 0.53% | (m) | Reported |
| 2011-09-30 | $112.49M | $2.25B | $12.17M | (m) | $22.60M | 4.99% | 0.54% | (m) | Reported |
| 2011-06-30 | $107.41M | $2.14B | $12.10M | (m) | $21.50M | 5.01% | 0.56% | (m) | Reported |
| 2011-03-31 | $100.91M | $2.05B | $12.56M | (m) | $20.51M | 4.92% | 0.61% | (m) | Reported |
| 2010-12-31 | $97.03M | $1.97B | $12.38M | (m) | $20.06M | 4.93% | 0.63% | (m) | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $89.69M | $1.73B | $11.37M | (m) | $25.12M | 5.19% | 0.66% | (m) | Reported |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $102.28M | $1.97B | $8.70M | (m) | $25.39M | 5.18% | 0.44% | (m) | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |